Becton Dickinson & Co (BDX): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2008-09-30, 2010-09-30, 2020-09-30 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$2.67B
Year ended 2025-09-30
+21.2%
3-year compound annual growth
+4.3%
5-year compound annual growth
$3.12B2007-09-30: $673.66M2008-09-30: $1.02B2009-09-30: $1.07B2010-09-30: $1.06B2011-09-30: $1.13B2012-09-30: $1.21B2013-09-30: $1.20B2014-09-30: $1.15B2015-09-30: $1.13B2020-09-30: $2.17B2021-09-30: $2.93B2022-09-30: $1.50B2023-09-30: $2.12B2024-09-30: $3.12B2025-09-30: $2.67B$2.67B
2007-09-30 Free Cash Flow (USD) 2025-09-30
Period endedFree Cash FlowChange YoYSource filing
2025-09-30$2.67B-14.4%2025-11-25, From 2024-10-01
2024-09-30$3.12B+47.4%2025-11-25, From 2023-10-01
2023-09-30$2.12B+41.3%2025-11-25, From 2022-10-01
2022-09-30$1.50B-48.9%2024-11-27, From 2021-10-01
2021-09-30$2.93B+35.2%2023-11-21, From 2020-10-01
2020-09-30$2.17Bn/c2022-11-22, From 2019-10-01
No annual figure between 2015-09-30 and 2020-09-30.
2015-09-30$1.13B-1.7%2017-11-22, From 2014-10-01
2014-09-30$1.15B-3.4%2016-11-23, From 2013-10-01
2013-09-30$1.20B-0.9%2015-11-25, From 2012-10-01
2012-09-30$1.21B+6.8%2014-11-26, From 2011-10-01
2011-09-30$1.13B+6.9%2013-11-27, From 2010-10-01
2010-09-30$1.06Bn/c2012-11-21, From 2009-10-01
2009-09-30$1.07B+5.0%2011-11-23, From 2008-10-01
2008-09-30$1.02Bn/c2010-11-24, From 2007-10-01
2007-09-30$673.66Mn/a2010-01-21, From 2006-10-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Becton Dickinson & Co (BDX)2025-09-30$2.67B-14.4%
Boston Scientific Corp (BSX)2025-12-31$3.66B+38.3%
3M Co (MMM)2025-12-31$1.40B+118.8%
Stryker Corp (SYK)2025-12-31$4.28B+22.8%
Medline Inc. (MDLN)2025-12-31$1.30B-8.3%
Baxter International Inc (BAX)2025-12-31$332.00M-42.1%
Solventum Corp (SOLV)2025-12-31-$10.00Mn/m
ResMed Inc (RMD)2026-06-30$1.65B-0.7%
Dexcom Inc (DXCM)2025-12-31$1.08B+70.8%

Compare BDX, BSX, MMM, SYK side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗